{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-042937","form_type":"8-K","ticker":"OPRX","cik":"0001448431","company_name":"OptimizeRx Corp","filed_at":"2024-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.464306+00:00","generated_at":"2026-06-02T00:39:29.961504+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"OptimizeRx Q1 revenue +51% to $19.7M; Adj EBITDA improves to $(0.3)M; reaffirms FY guidance","bullets":["Revenue $19.7M, +51% YoY; gross profit $12.2M, +64% YoY.","GAAP net loss $(6.9)M ($0.38/share); Non-GAAP net loss $(2.0)M ($0.11/share).","Adjusted EBITDA improved to $(0.3)M from $(2.2)M a year ago.","Won 9 DAAP (AI-platform) deals in Q1; Net Revenue Retention 116% vs 86%.","Reiterated FY2024 guidance: revenue at least $100M, Adj EBITDA at least $11M."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-042937","json":"https://secwatch.observer/filing/0001213900-24-042937.json","markdown":"https://secwatch.observer/filing/0001213900-24-042937.md","text":"https://secwatch.observer/filing/0001213900-24-042937.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1448431/000121390024042937/0001213900-24-042937-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1448431/000121390024042937/ea0206046-8k_optimize.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T00:39:29.961504+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b2cc82a69495e14492239a38eabb8a71af0a44f8","claim":"OptimizeRx Corp reported financial results for the first quarter ended March 31, 2024.","evidence_excerpt":"On May 14, 2024, OptimizeRx Corporation issued a press release announcing its financial results for the first quarter ended March 31, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1448431/000121390024042937/0001213900-24-042937-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}